Skip to main content
Caplight Logo









Keyron Medical Technology

Keyron Medical Technology

Private
LondonHealthcare & Life Scienceshttps://keyron.com/

Last Round

Accelerator

Sep 6, 2024

Est. Valuation

$375,000

Total Funding Raised

$610,000

Company Overview

Keyron Medical Technology is a medical devices & equipment company developing ForePass®, a minimally-invasive, implantable alternative to gastric bypass surgery designed to reverse type-2 diabetes, NASH, and obesity.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceendoscopic implantmetabolic surgerybariatric surgeryminimally invasive surgerymetabolic diseasetype 2 diabetesobesity treatmentNASHnon-alcoholic steatohepatitismedtechendoscopygastric bypass alternativereversible implantbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Keyron Medical Technology Comparables

Compare Keyron Medical Technology with similar companies based on industry and business-model similarity.

Keyron Medical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MetaModix
91%
EndoSphere
83%
Morphic Medical
83%

Keyron Medical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 6, 2024
SeedDec 22, 2021

Key People

Founding team and executive leadership

Giorgio Castagneto Gissey

CEO

Executive Team

Jayme McGillis

Consulting COO

Executive Team

Keyron Medical Technology Investors

Notable investors and investment history

Keyron Medical Technology investors
InvestorRounds
LIFTT EuroInvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 6, 2024

    $30K round led by Health Wildcatters

Keyron Medical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Keyron Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Keyron Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2016
Last FundingSep 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?